Insider · CIK 0001714949
Nancy Ryan Gray
Files at LGND (LIGAND PHARMACEUTICALS INC). First filing Nov 12, 2025, latest Nov 12, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LGND: LIGAND PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | LIGAND PHARMACEUTICALS INC | $1.4M 6,571 shares | -56% | +109% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock | +3,556 | $66.19 | $235k | 11,650 | Nov 12, 2025 |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -3,556 | $205.45 | $731k | 8,094 | Nov 12, 2025 |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock | +3,015 | $73.57 | $222k | 11,109 | Nov 12, 2025 |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -3,015 | $205.45 | $619k | 8,094 | Nov 12, 2025 |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -3,556 | $0.00 | $0 | 0 | Nov 12, 2025 |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -3,015 | $0.00 | $0 | 0 | Nov 12, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +1,209 | $0.00 | $0 | 8,094 | Jun 10, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +5,783 | $0.00 | $0 | 5,783 | Jun 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.